Re: Multi-institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer. Babjuk M. Eur Urol 2020 May 3. pii: S0302-2838(20)30252.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Babjuk M. Re: Multi-institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer. Eur Urol 2020 May 3. pii: S0302-2838(20)30252.
PMID: 32376135